Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SNDA · against 1,216 other Healthcare companies
Ranked #117 of 1,217 · scores higher than 90% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including SNDA · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | SNDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 49.4% | 6.1% | 90% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 29.0% | 5.8% | 87% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 117 | 5.7B USD | 90 | 30 | |
| 117 | 7.4B USD | 90 | 67 | |
| 117 | 302M USD | 90 | 42 | |
| 117 | 3.8B USD | 90 | 48 | |
| 117 | 1.6B USD | 90 | 43 | |
| 117 | 2.1B USD | 90 | 61 | |
| 129 | 3.1B CNY (≈$438M) | 89 | 46 | |
| 129 | 1.18T KRW (≈$847M) | 89 | 63 | |
| 129 | 68.9B HKD (≈$8.8B) | 89 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score